诺诚健华：2024年股东周年大会会议资料

查股网 2024-04-27 诺诚健华(688428)公司公告

InnoCare Pharma

(1)(2)(3)(4)

(5)(6)(7)

(8)(9)

(10)

88AGM-1AGM-8(www.hkexnews.hk)( www.innocarepharma.com)

17M

– i –

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

1.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7

2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7

3.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7

4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

5.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

6. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9

7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10

8. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11

9.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11

10. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12

11.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12

12. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13

13.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13

14. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13

15.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14

16. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14

17. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15

— . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I-1

— . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . II-1

— . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . III-1

— . . . . . . . . . . . . . . . . . . IV-1

— . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V-1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . AGM-1

– 1 –

AGM-1AGM-8

9969688428

– 2 –

93%7%

0.000002

III-2

– 3 –

– 4 –

a.b.

0.000002

– 5 –

1.01

– 6 –

InnoCare Pharma

Ogier Global (Cayman) Limited89 Nexus Way, Camana BayGrand Cayman, KY1-9009Cayman Islands

(1)(2)(3)(4)

(5)(6)(7)

(8)(9)

(10)

– 7 –

AGM-1AGM-8

(1)(2)(3)

(4)(5)(6)

(7)(8)

(9)

(http://www.sse.com.cn)(http://www.hkexnews.hk)(www.innocarepharma.com)

(http://www.hkexnews.hk)(http://www.sse.com.cn)(www.innocarepharma.com)

– 8 –

20%

1,762,582,452

352,516,4907

– 9 –

520%

10%

1,497,934,235264,648,2177

149,793,42326,464,821

114.(a)

– 10 –

(a)

(b) 3.13

(c)

– 11 –

3.13

– 12 –

10.

11.

(i)(ii)

– 13 –

12.

183171712-1716

13.

AGM-1AGM-8

(i)(ii)(iii)

14.

( www.hkexnews.hk)( www.innocarepharma.com)

– 14 –

15.

16.

– 15 –

17.

(1)(2)

(3)(4)

(5)(6)(7)

(8)(9)

– I-1 –

2023

—

2023

2023NMPAMZLMZLBTKtafasitamab

13I/II/III

2.0

2023

202315

– I-2 –

12023.01.19222023.02.15132023.03.271742023.04.20152023.04.261462023.05.09272023.06.02282023.07.11292023.07.142102023.08.116112023.08.293122023.09.081132023.10.114142023.11.132152023.12.152

1 A

277,881.562023

20222023

– I-3 –

—

— A

—

– I-4 –

20232

– I-5 –

2023

20237

20236

20233

– I-6 –

2024

—

2024328

– II-1 –

13.51(2)

Ph.D.56

(PrincetonUniversity)

(The National Science Fund for Distinguished

Young Scholars)(The Irving Sigal YoungInvestigator Award)(The

Raymond & Beverly Sackler International Prize)

(The Gregori Aminoff Prize,

Royal Swedish Academy of Sciences)

– II-2 –

(The National Innovation Award)

Structures of the Human Spliceosomes Before and After Release of the Ligated

ExonStructures of the Catalytically Activated Yeast Spliceosome Reveal the Mechanism of

Branching Recognition of the Amyloid Precursor Protein by Human–Secretase Structural Basis of Notch Recognition by Human–Secretase Structure of a Human Catalytic Step I SpliceosomeStructures of the Fully Assembled Saccharomyces Cerevisiae Spliceosome Before

Activation Structure of the Human PKD1/PKD2 Complex Structures of the Human Pre-Catalytic Spliceosome and its Precursor Spliceosome

(Johns Hopkins University)

XV116,839,593

– II-3 –

5020

1875

Arthur Andersen

CICPA

– II-4 –

30,000

ArriVent Biopharma, Inc.ArriVent Biopharma, Inc.

Vivo Capital LLCVivo Capital LLCVivo CapitalVivo PANDA FundVivoInnovation Fund II

Pre-doctoral Fellowship

30,000

– II-5 –

3.13

(i)(ii)(iii)

13.51(2)(h)(v)

– III-1 –

10%10%

(i)(ii)12(iii)(iv)

(v)

1,497,934,235264,648,217

10%

149,793,423

– III-2 –

26,464,82110%

– III-3 –

(i)

(ii)

(iii)

– III-4 –

HHLR Advisors, Ltd.208,671,22211.84%HHLRAdvisors, Ltd.13.15%

1,650,0005.134.548,138,430

548,0006.005.603,162,780180,0006.666.461,191,470

2,378,00012,492,680

– III-5 –

10.907.90

9.607.08

8.386.45

8.387.05

8.376.56

6.845.67

6.385.31

7.495.93

6.975.88

6.955.28

5.554.50

5.514.61

5.064.03

– IV-1 –

64.(a)

97.(b)

– IV-2 –

185.(b)(c)

– IV-3 –

185.(c)185.(c)

– IV-4 –

190.(b)

191.(a)191.(a)[]

– IV-5 –

191.(b)

(b)

191.(b)

[]

(b)

– IV-6 –

191.(c)

(b)

191.(c)

[]

(b)

– IV-7 –

192.192.

(a)

(b)

(c)

(d)(e)

– IV-8 –

193.193.

195.195.

– V-1 –

20187

93,000

86,490

130,000

2024328

– V-2 –

2018814

91440101MA5C44KG8LCUI Jisong100,000

93%7%

– V-3 –

20231231208,551.13161,182.99

47,368.1420238,623.37–20,097.07–15,484.74 20231231

– V-4 –

293,740

41.09%

18.19%12

170,000

17.14%

13.10%

– AGM-1 –

InnoCare Pharma

2.3.4.5.

(i) (iii)

(v)

– AGM-2 –

(ii) (i)

(iii) (i)

(1) (v)(2)

(3)

(4)

20%

– AGM-3 –

(i)

(v)(ii)

(iv)

(v)

(a) (1)

(2)

(i)(ii)

(iii)

(b)

(1)(2)

(3)

– AGM-4 –

(c)

(i) (ii)(iv)

(ii) (i)

10%

(iii) (i)

10%

– AGM-5 –

(iv) (i)(ii)(iii)(i)(ii)(iii)

(v)

(a)(b)

(c)

(d) 12(e)7.

– AGM-6 –

10%10%8.9.10.11.12.13.

14.15.

16.

– AGM-7 –

(i) 567(ii)(iii)

(iv)

18317M

(v)

183171712-1716(vi) 8

(vii) 5

– AGM-8 –

(viii) 6

(ix)(x)

附件：公告原文